UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Value in health, ISSN 1098-3015, 2017, Volume 20, Issue 3, pp. 487 - 495
Internal Medicine | health technology assessment | clinical outcome assessment | surrogate end points | validation | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | Quality-Adjusted Life Years | Disease-Free Survival | Medical Oncology | United States | Humans | Biomarkers | Treatment Outcome | Clinical Trials as Topic | Evidence-Based Medicine | Health Policy | United States Food and Drug Administration | Technology Assessment, Biomedical | Drugs | Medical technology | Health professional-Patient communication | Health care policy | Clinical trials | Clinical research | Efficacy | Coverage | Medical supplies | Patients | Clinical outcomes | Morbidity | Policy making | Validity | Biological markers | Surrogates | Index Medicus
Journal Article
Chest, ISSN 0012-3692, 01/2005, Volume 127, Issue 1, pp. 171 - 177
mortality | efficacy end points | idiopathic pulmonary fibrosis | percentage of predicted FVC | arterial-alveolar pressure gradient | Percentage of predicted FVC | Arterial-alveolar pressure gradient | Efficacy end points | Idiopathic pulmonary fibrosis | Mortality | Cardiology. Vascular system | Antiviral agents | Respiratory system : syndromes and miscellaneous diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Pneumology
Journal Article
BioFactors (Oxford), ISSN 0951-6433, 2003, Volume 18, Issue 1‐4, pp. 79 - 89
heart failure | coenzyme Q10 | clinical trials | safety | efficacy | Heart failure | Clinical trials | Coenzyme Q | Efficacy | Safety | Coenzymes | Double-Blind Method | Cardiac Output, Low - mortality | Humans | Ubiquinone - analogs & derivatives | Placebos | Ubiquinone - therapeutic use | Treatment Outcome | Cardiac Output, Low - drug therapy | Controlled Clinical Trials as Topic | Ubiquinone - adverse effects | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Cardiovascular revascularization medicine, ISSN 1553-8389, 10/2018, Volume 19, Issue 7, pp. 785 - 791
Journal Article
Expert review of clinical pharmacology, ISSN 1751-2433, 01/2016, Volume 9, Issue 1, pp. 81 - 89
frailty | functional status | pharmacodynamics | safety | therapeutic goals | drug development | older adults | pharmacokinetics | efficacy | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Acute Disease | Drugs, Investigational - adverse effects | Age Factors | Patient-Centered Care - methods | Humans | Endpoint Determination | Drugs, Investigational - therapeutic use | Aged | Frail Elderly | Health Status | Chronic Disease | Disabled Persons
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2016, Volume 67, Issue 4, pp. 353 - 361
simvastatin | ezetimibe | low-density lipoprotein cholesterol | total events | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Myocardial Infarction - blood | United States - epidemiology | Myocardial Infarction - epidemiology | Survival Rate - trends | Follow-Up Studies | Simvastatin - administration & dosage | Humans | Middle Aged | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Ezetimibe - administration & dosage | Acute Coronary Syndrome - blood | Incidence | Acute Coronary Syndrome - drug therapy | Dose-Response Relationship, Drug | Time Factors | Anticholesteremic Agents - administration & dosage | Cholesterol, LDL - blood | Female | Aged | Myocardial Infarction - prevention & control | Drug Therapy, Combination | Coronary artery bypass | Low density lipoproteins | Analysis | Cardiac patients | Heart attack | Anticholesteremic agents | Index Medicus | Abridged Index Medicus | metaanalysis | moderate statin therapy | high-risk | Klinisk medicin | atorvastatin | end-points | efficacy | Clinical Medicine | myocardial-infarction | cholesterol | randomized-trials
Journal Article
European journal of ophthalmology, ISSN 1120-6721, 3/2020, Volume 30, Issue 2, pp. 321 - 349
clinical trials | Centralised Procedure | efficacy | end-points | Regulatory approval | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Drug Approval - statistics & numerical data | Ophthalmology - statistics & numerical data | Risk Assessment | European Union | Humans | Treatment Outcome | Retrospective Studies
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 01/2017, Volume 28, Issue 1, pp. 368 - 375
TRIAL | ATRIAL-NATRIURETIC-PEPTIDE | GLUCOSE CONTROL | GFR DECLINE | EFFICACY | SAFETY | DOUBLE-BLIND | END-POINTS | CHRONIC KIDNEY-DISEASE | EMPAGLIFLOZIN | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Hypoglycemic Agents - therapeutic use | Albuminuria - etiology | Double-Blind Method | Canagliflozin - pharmacology | Diabetic Nephropathies - etiology | Humans | Middle Aged | Sulfonylurea Compounds - therapeutic use | Male | Albuminuria - prevention & control | Disease Progression | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Hypoglycemic Agents - pharmacology | Canagliflozin - therapeutic use | Sulfonylurea Compounds - pharmacology | Female | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Index Medicus | renal function | Clinical Research | SGLT2 | diabetic nephropathy | canagliflozin
Journal Article
European journal of heart failure, ISSN 1388-9842, 04/2018, Volume 20, Issue 4, pp. 760 - 768
Heart failure | Hospitalization | Recurrent events | Neprilysin inhibitor | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Morbidity - trends | Recurrence | United States - epidemiology | Prospective Studies | Survival Rate - trends | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Europe - epidemiology | Male | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Tetrazoles - administration & dosage | Female | Aged | Aminobutyrates - administration & dosage | Enalapril - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Heart Failure - mortality | Index Medicus | Focus on Prognostic Variables | enalapril | time data | efficacy | Kardiologi | Cardiac and Cardiovascular Systems | clinical-trials | regression | model | receptor neprilysin inhibition | composite end-points | hospitalizations
Journal Article
International journal of cardiology, ISSN 0167-5273, 02/2018, Volume 253, pp. 91 - 96
Clinical trials | Prognosis | Site selection | Acute heart failure | EVEREST EFFICACY | ACUTE HEART-FAILURE | MANAGEMENT | CLINICAL-TRIALS | GLOBALIZATION | TOLVAPTAN | END-POINTS | VASOPRESSIN ANTAGONISM | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Natriuretic peptides | Index Medicus
Journal Article
Journal of comparative effectiveness research, ISSN 2042-6305, 08/2020, Volume 9, Issue 14, pp. 973 - 984
Journal Article
Inflammatory bowel diseases, ISSN 1078-0998, 09/2013, Volume 19, Issue 10, pp. 2125 - 2131
CROHNS-DISEASE | TOXIN | Clostridium difficile | real-time polymerase chain reaction | ULCERATIVE-COLITIS | ACTIVITY INDEXES | inflammatory bowel disease | exacerbation | REAL-TIME PCR | MEDICAL THERAPY | EFFICACY END-POINTS | CLINICAL-TRIALS | RESISTANCE | INFECTION | bacterial pathogen | Exacerbation | Inflammatory bowel disease | Bacterial pathogen | Real-time polymerase chain reaction | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Recurrence | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Colitis, Ulcerative - pathology | Enterocolitis, Pseudomembranous - microbiology | Clostridium difficile - pathogenicity | Enterocolitis, Pseudomembranous - complications | Feces - microbiology | Netherlands | Colitis, Ulcerative - etiology | Crohn Disease - pathology | Adult | Female | Retrospective Studies | Enterocolitis, Pseudomembranous - diagnosis | Chronic Disease | Crohn Disease - etiology | Index Medicus
Journal Article